THERABRON THERAPEUTICS, INC.

Profile

Company Names

THERABRON THERAPEUTICS, INC.
CLARASSANCE, INC.

Addresses

9430 KEY WEST AVENUE, SUITE 150, ROCKVILLE, MD 20850

9430 KEY WEST AVENUE, #150, ROCKVILLE, MD 20850

9430 KEY WEST AVENUE, #125, ROCKVILLE, MD 20850

9700 GREAT SENECA HIGHWAY, ROCKVILLE, MD 20850

Phone Numbers

240-205-7275
240-205-7271
301-452-2899

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$15,570,523.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2016-12-12 
$2,325,000.00 
$6,045,000.00 
$3,720,000.00 
Debt 
4
2015-11-03 
$5,500,000.00 
$6,749,998.00 
$1,249,998.00 
Equity 
3
2014-06-04 
$7,180,523.00 
$7,180,523.00 
$0.00 
Equity 
2
2012-09-04 
$250,000.00 
$2,500,000.00 
$2,250,000.00 
Equity 
1
2010-10-27 
$315,000.00 
$1,000,000.00 
$685,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TODD 
 
BRADY 
DIRECTOR
NOVADIGM THERAPEUTICS INC   |  ASMACURE, INC.   |  EVOKE PHARMA INC   |  SEBACIA, INC.   |  ALDEXA THERAPEUTICS, INC.   |  RX GREEN SOLUTIONS LLC   |  ONCOBIOLOGICS, INC.   |  TYROGENEX, INC.   |  THERABRON THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES LLC   |  GENO LLC   |  ALDEYRA THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES, INC.   |  VERO BIOTECH INC.   |  HYPERFRAME INC.
LINDA 
 
CHANG 
EXECUTIVE OFFICER
ARMOR MINERALS INC.   |  THERABRON THERAPEUTICS, INC.
CHRISTINE 
 
COPPLE 
DIRECTOR, EXECUTIVE OFFICER
CLARASSANCE, INC.   |  THERABRON THERAPEUTICS, INC.   |  BIOTECH HOLDINGS, LLC
BLANCHE 
 
JOHNSON 
EXECUTIVE OFFICER, DIRECTOR
CLARASSANCE, INC.
BLANCHE 
M 
JOHNSON 
DIRECTOR
THERABRON THERAPEUTICS, INC.
BLANCHE 
M. 
JOHNSON 
EXECUTIVE OFFICER, DIRECTOR
THERABRON THERAPEUTICS, INC.
THOMAS 
 
MILLER 
EXECUTIVE OFFICER
CAPITAL ASSET MANAGEMENT FUND, L.P.   |  SOCKET MOBILE, INC.   |  APARICIO COMMUNITY APARTMENTS, L.P.   |  SENO MEDICAL INSTRUMENTS, INC   |  FOX FRAME PRODUCTIONS, INC.   |  INTELLIGENT MEDICAL DEVICES, INC.   |  THERABRON THERAPEUTICS, INC.   |  EAGLE RIVER CAPITAL, LLC   |  LET IT FLY NEBRASKA, LLC   |  POLICY CONFLUENCE, INC.   |  IAMBIC THERAPEUTICS, INC.   |  HAVEN FUND II LLC   |  STOLTZ REAL ESTATE FUND VIII, L.P.   |  STOLTZ STRATEGIC GROWTH FUND I, L.P.   |  SREF VIII REIT HOLDINGS, LLC   |  SSGF I REIT HOLDINGS, LLC
APRILE 
 
PILON-CLAYTON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLARASSANCE, INC.
APRILE 
L 
PILON-CLAYTON 
EXECUTIVE OFFICER, DIRECTOR
THERABRON THERAPEUTICS, INC.
APRILE 
L. 
PILON-CLAYTON 
EXECUTIVE OFFICER, DIRECTOR
THERABRON THERAPEUTICS, INC.
VINZENZ 
 
PLOERER 
DIRECTOR, EXECUTIVE OFFICER
CLARASSANCE, INC.   |  THERABRON THERAPEUTICS, INC.   |  NAVITOR PHARMACEUTICALS, INC.   |  TYROGENEX, INC.   |  ANTIVA BIOSCIENCES, INC.   |  GENO LLC
ERIC 
 
RICHMAN 
DIRECTOR
THERABRON THERAPEUTICS, INC.   |  LABCONNECT HOLDINGS, INC.   |  INFUSE HOLDINGS, INC.   |  ZYVERSA THERAPEUTICS, INC.   |  NEUBASE THERAPEUTICS, INC.
JEFFREY 
 
ZELL 
DIRECTOR
CLARASSANCE, INC.
JEFFREY 
M 
ZELL 
DIRECTOR
THERABRON THERAPEUTICS, INC.
JEFFREY 
M. 
ZELL 
DIRECTOR
THERABRON THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-12-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-12 
2015-11-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-03 
2014-06-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-04 
2012-09-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-04 
2011-11-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-27 
2010-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#